Press Releases about AN2 Therapeutics, Inc. - Common Stock
![](https://mms.businesswire.com/media/20240828371113/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20240816585924/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
AN2 Therapeutics Adopts Limited Duration Stockholder Rights Plan
August 16, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240813783660/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20240808125351/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20240514775764/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20240328333538/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20240212430072/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20240130626235/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20231109308786/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20231106781305/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 06, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231018590682/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20231010060919/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023
October 11, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230926590651/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20230913252729/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20230815851416/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20230810314462/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20230525005314/en/1447127/5/an2_therapeutics_logo_weba_%28003%29.jpg)
![](https://mms.businesswire.com/media/20230510006124/en/1447127/5/an2_therapeutics_logo_weba_%28003%29.jpg)
![](https://mms.businesswire.com/media/20230501005119/en/1694868/5/an2_therapeutics_logo_weba_%28003%29.jpg)
![](https://mms.businesswire.com/media/20230328005954/en/1447127/5/an2_therapeutics_logo_weba_%28003%29.jpg)
![](https://mms.businesswire.com/media/20230228006237/en/1694868/5/an2_therapeutics_logo_weba_%28003%29.jpg)
AN2 Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230131005415/en/1694868/5/an2_therapeutics_logo_weba_%28003%29.jpg)
Via Business Wire
![](https://ml.globenewswire.com/media/caafb35e-ab8e-45e0-a580-016c3e869a55/small/an2-linkedin-2-jpg.jpg)
![](https://ml.globenewswire.com/media/caafb35e-ab8e-45e0-a580-016c3e869a55/small/an2-linkedin-2-jpg.jpg)
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 02, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/caafb35e-ab8e-45e0-a580-016c3e869a55/small/an2-linkedin-2-jpg.jpg)
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022
October 19, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/244a98ea-f1aa-4e63-a545-015333e9d8dd/small/an2-therapeutics-logo-weba-jpg.jpg)
![](https://ml.globenewswire.com/media/244a98ea-f1aa-4e63-a545-015333e9d8dd/small/an2-therapeutics-logo-weba-jpg.jpg)
![](https://mms.businesswire.com/media/20220509005229/en/1447136/5/an2_therapeutics_logo_weba_%28003%29.jpg)
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
May 20, 2021
Topics
Death
Exposures
Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.